Evaluation of protein kinase CK2 as a therapeutic target for squamous cell carcinoma of cats (Q48713759)

14 February 2018

http://europepmc.org/abstract/MED/28738012

title

Evaluation of protein kinase CK2 as a therapeutic target for squamous cell carcinoma of cats (English)

1 reference

14 February 2018

http://europepmc.org/abstract/MED/28738012

author

Janeen Trembley

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6668352&resulttype=core&format=json

15 May 2020

Jaime Modiano

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6668352&resulttype=core&format=json

15 May 2020

3

Betsy T Kren

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6668352&resulttype=core&format=json

15 May 2020

4

Gretchen M Unger

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6668352&resulttype=core&format=json

15 May 2020

author name string

Claire M Cannon

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6668352&resulttype=core&format=json

15 May 2020

M Gerard O'Sullivan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6668352&resulttype=core&format=json

15 May 2020

Ingrid Cornax

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6668352&resulttype=core&format=json

15 May 2020

Khalil Ahmed

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6668352&resulttype=core&format=json

15 May 2020

language of work or name

English

0 references

publication date

1 August 2017

1 reference

14 February 2018

http://europepmc.org/abstract/MED/28738012

published in

American Journal of Veterinary Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6668352&resulttype=core&format=json

15 May 2020

volume

78

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6668352&resulttype=core&format=json

15 May 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6668352&resulttype=core&format=json

15 May 2020

page(s)

946-953

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6668352&resulttype=core&format=json

Nuclear matrix targeting of the protein kinase CK2 signal as a common downstream response to androgen or growth factor stimulation of prostate cancer cells

15 May 2020

cites work

1 reference

12 December 2020

Protein kinase CK2 and its role in cellular proliferation, development and pathology

1 reference

12 December 2020

The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation

1 reference

12 December 2020

A potential role of nuclear matrix-associated protein kinase CK2 in protection against drug-induced apoptosis in cancer cells

1 reference

12 December 2020

Protein kinase CK2 signal in neoplasia

1 reference

12 December 2020

Protein kinase CK2 in mammary gland tumorigenesis

1 reference

12 December 2020

Protein kinases and adherens junction dynamics in the seminiferous epithelium of the rat testis

1 reference

12 December 2020

Induction of apoptosis by antisense CK2 in human prostate cancer xenograft model.

1 reference

12 December 2020

CK2 inhibits apoptosis and changes its cellular localization following ionizing radiation

1 reference

12 December 2020

Caspase-2 primes cancer cells for TRAIL-mediated apoptosis by processing procaspase-8

1 reference

12 December 2020

CK2 as a positive regulator of Wnt signalling and tumourigenesis

1 reference

12 December 2020

Inducible IkappaB kinase/IkappaB kinase epsilon expression is induced by CK2 and promotes aberrant nuclear factor-kappaB activation in breast cancer cells

1 reference

12 December 2020

Protein kinase CK2 subunits are positive regulators of AKT kinase

1 reference

12 December 2020

Multiple myeloma cell survival relies on high activity of protein kinase CK2.

1 reference

12 December 2020

Casein kinase 2 (CK2) increases survivin expression via enhanced beta-catenin-T cell factor/lymphoid enhancer binding factor-dependent transcription

1 reference

12 December 2020

Nuclear localization of protein kinase CK2 catalytic subunit (CK2alpha) is associated with poor prognostic factors in human prostate cancer

1 reference

12 December 2020

Protein kinase CK2alpha as an unfavorable prognostic marker and novel therapeutic target in acute myeloid leukemia.

1 reference

12 December 2020

Phosphorylation of murine caspase-9 by the protein kinase casein kinase 2 regulates its cleavage by caspase-8.

1 reference

12 December 2020

Protein kinase CK2--a key suppressor of apoptosis

1 reference

12 December 2020

Protein kinase CK2 in human diseases.

1 reference

12 December 2020

PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability

1 reference

12 December 2020

Protein kinase CK2 in health and disease: CK2: a key player in cancer biology

1 reference

12 December 2020

Addiction to protein kinase CK2: a common denominator of diverse cancer cells?

1 reference

12 December 2020

Feline head and neck squamous cell carcinoma: a natural model for the human disease and development of a mouse model.

1 reference

12 December 2020

Activity of protein kinase CK2 uncouples Bid cleavage from caspase-8 activation.

1 reference

12 December 2020

CK2 modulation of NF-kappaB, TP53, and the malignant phenotype in head and neck cancer by anti-CK2 oligonucleotides in vitro or in vivo via sub-50-nm nanocapsules.

1 reference

12 December 2020

Emergence of protein kinase CK2 as a key target in cancer therapy

1 reference

12 December 2020

Progesterone augments proliferation induced by epidermal growth factor in a feline mammary adenocarcinoma cell line

1 reference

12 December 2020

Bone-invasive oral squamous cell carcinoma in cats: pathology and expression of parathyroid hormone-related protein

1 reference

12 December 2020

CX-4945, an Orally Bioavailable Selective Inhibitor of Protein Kinase CK2, Inhibits Prosurvival and Angiogenic Signaling and Exhibits Antitumor Efficacy

1 reference

12 December 2020

Protein kinase CK2α subunit over-expression correlates with metastatic risk in breast carcinomas: quantitative immunohistochemistry in tissue microarrays

1 reference

12 December 2020

Overexpression of Nuclear Protein Kinase CK2 α Catalytic Subunit (CK2α) as a Poor Prognosticator in Human Colorectal Cancer

1 reference

12 December 2020

Inhibition of experimental HCC growth in mice by use of the kinase inhibitor DMAT.

1 reference

12 December 2020

Systemic administration of antisense oligonucleotides simultaneously targeting CK2α and α' subunits reduces orthotopic xenograft prostate tumors in mice

1 reference

12 December 2020

Nanoencapsulated anti-CK2 small molecule drug or siRNA specifically targets malignant cancer but not benign cells

1 reference

12 December 2020

Characterization of bone resorption in novel in vitro and in vivo models of oral squamous cell carcinoma.

1 reference

12 December 2020

Protein kinase CK2 in hematologic malignancies: reliance on a pivotal cell survival regulator by oncogenic signaling pathways

1 reference

12 December 2020

TF--a novel cell-permeable and selective inhibitor of human protein kinase CK2 induces apoptosis in the prostate cancer cell line LNCaP.

1 reference

12 December 2020

A naturally occurring feline model of head and neck squamous cell carcinoma

1 reference

12 December 2020

Mechanism and efficacy of sub-50-nm tenfibgen nanocapsules for cancer cell-directed delivery of anti-CK2 RNAi to primary and metastatic squamous cell carcinoma.

1 reference

12 December 2020

Casein kinase 2α regulates glioblastoma brain tumor-initiating cell growth through the β-catenin pathway

1 reference

12 December 2020

Tenfibgen ligand nanoencapsulation delivers bi-functional anti-CK2 RNAi oligomer to key sites for prostate cancer targeting using human xenograft tumors in mice

1 reference

12 December 2020

CK2α, over-expressed in human malignant pleural mesothelioma, regulates the Hedgehog signaling pathway in mesothelioma cells

1 reference

12 December 2020

1 reference

12 December 2020

Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy

1 reference

12 December 2020

Oral field cancerization: an update on current concepts

1 reference

12 December 2020

Protein Kinase CK2 Expression Predicts Relapse Survival in ERα Dependent Breast Cancer, and Modulates ERα Expression in Vitro

1 reference

12 December 2020

Potent and Selective CK2 Kinase Inhibitors with Effects on Wnt Pathway Signaling in Vivo

1 reference

12 December 2020

Activation of a tumor-associated protein kinase (p40TAK) and casein kinase 2 in human squamous cell carcinomas and adenocarcinomas of the lung

1 reference

12 December 2020

Growth stimulus-mediated differential translocation of casein kinase 2 to the nuclear matrix. Evidence based on androgen action in the prostate

1 reference

12 December 2020

Asymmetric expression of protein kinase CK2 subunits in human kidney tumors

1 reference

12 December 2020

Casein kinases: pleiotropic mediators of cellular regulation

1 reference

12 December 2020

Elevated protein kinase CK2 activity in chromatin of head and neck tumors: association with malignant transformation.

1 reference

12 December 2020

Identifiers

DOI

10.2460/AJVR.78.8.946

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6668352&resulttype=core&format=json

15 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6668352&resulttype=core&format=json

15 May 2020

1 reference